Feature Channels: Vaccines

• share
• favorite_border

While many parents have gotten their children vaccinated, some families have questions about the vaccine’s safety and efficacy. We spoke to several experts at Children’s Hospital Los Angeles, including Michael Smit, MD, MSPH, Hospital Epidemiologist and Medical Director of Infection Prevention and Control, and Marisa Glucoft, MPH, Vice President of Quality Improvement and Patient Safety, to answer some frequently asked questions.

• share
• favorite_border

An outbreak of the Marburg virus in Rwanda has prompted public health officials to announce they will start screening travelers to the US who have also been in Rwanda in the last 21 days. The George... ...

• share
• favorite_border

LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Professor Sujan Shresta, Ph.D., is on hand to share her expertise on dengue fever and dengue vaccine development. She is available to comment on urgent dengue virus research amidst the news of San Diego’s first locally acquired dengue virus case. LJI Professor Sujan Shresta, Ph.

• share
• favorite_border

• share
• favorite_border

New research from the Salvino lab identifies novel series of MPro inhibitors

• share
• favorite_border

• share
• favorite_border

A cancer vaccine that had little success in clinical trials for patients with advanced tumors could potentially have efficacy if administered earlier in the treatment cycle, according to a study from Vanderbilt researchers.

• share
• favorite_border

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.

• share
• favorite_border

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government’s Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

• share
• favorite_border

Irvine, Calif., Oct. 3, 2024 — With an initial three-year, $33 million grant from the National Institute of Allergy and Infectious Diseases, the University of California, Irvine will lead a multi-institutional drive to create new vaccines as part of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness Network (ReVAMPP).

• share
• favorite_border

• share
• favorite_border

Research shows people previously vaccinated against mpox in 2022 had declining antibody responses after six to 12 months, as World Health Organization (WHO) designates the 2024 mpox outbreak a public health emergency of international concern.

• share
• favorite_border

Since May 18, 2022, cases of mpox have been spreading in the United States, including California. Since August 2024, there has been a new outbreak declared due to a significant increase in cases from the Democratic Republic of Congo and its neighboring countries in Central and East Africa. Here's everything families need to know about mpox.

• share
• favorite_border

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the United States each year, according to the Centers for Disease Control and Prevention. New images of the virus from researchers at the University of Wisconsin–Madison may hold the key to preventing or slowing RSV infections.

• share
• favorite_border

September usually marks the start of flu season, and with the ongoing threat of COVID-19, it’s crucial to be vigilant about your family’s health. The challenge, however, is being able to tell the difference between the flu, the common cold, respiratory syncytial virus (RSV) and COVID-19, since all have similar symptoms.

• share
• favorite_border

A study of more than 28,000 pregnancies from 2022 has found that the majority of pregnant people received the COVID-19 vaccine during its initial release.

• share
• favorite_border

In a new study funded by the National Institutes of Health, University of Georgia researchers found that natural immunity from previous flu infections has a significant impact on how well future influenza vaccinations work.

• share
• favorite_border

Researchers at WashU Medicine have received a $12 million grant from the National Institute of Allergy and Infectious Diseases to identify the factors that are responsible for long-lasting immunity against disease.

• share
• favorite_border

Rabies is a virus that affects the central nervous system in mammals, leading to brain inflammation. Rabies is almost always fatal once there are symptoms, but it is also 100 percent preventable with proper precautions and vaccination. Understanding the risks and taking preventative measures is essential in protecting animals, families, and communities.